Showing results (241-250 of 735) with videos related to
Sort By:
Pageof 74
The European Respiratory Journal|September 29, 2012
Survival of lung adenocarcinoma patients with malignant pleural effusionShang-Gin Wu, Chong-Jen Yu, Meng-Feng Tsai, et al.PLOS Digital Health|February 23, 2026
First-line risk stratification with machine learning models facilitates rapid triage for non-ST-elevation myocardial infarctionWei-Jia Luo, Yih-Mei Liou, Cheng-Han Hsiao, et al.Chest|July 30, 2011
Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatmentKuei-Pin Chung, Yen-Tsung Huang, Yih-Leong Chang, et al.Respiratory Medicine|May 27, 2009
Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patientsChun-Ta Huang, Yi-Ju Tsai, Chin-Chung Shu, et al.Cell Biology International|August 26, 2010
Identification of microRNAs expressed highly in pancreatic islet-like cell clusters differentiated from human embryonic stem cellsBo-Zhi Chen, Sung-Liang Yu, Sher Singh, et al.Lung Cancer (Amsterdam, Netherlands)|September 14, 2010
Comparison of gefitinib and erlotinib in advanced NSCLC and the effect of EGFR mutationsJenn-Yu Wu, Shang-Gin Wu, Chih-Hsin Yang, et al.Oncology|July 16, 2005
Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and Paclitaxel as first-line treatmentChih-Hsin Yang, Min-Chun Chen, Ann-Lii Cheng, et al.Carcinogenesis|May 2, 2013
Depletion of 4E-BP1 and regulation of autophagy lead to YXM110-induced anticancer effectsChin-Yu Lai, Shiow-Lin Pan, Xiao-Ming Yang, et al.ACS Nano|October 3, 2018
Targeting Tumor Microenvironment by Bioreduction-Activated Nanoparticles for Light-Triggered VirotherapyS-Ja Tseng, Ivan M Kempson, Kuo-Yen Huang, et al.Emerging Infectious Diseases|June 8, 2007
Diagnosis of tuberculosis by an enzyme-linked immunospot assay for interferon-gammaJann-Yuan Wang, Chien-Hong Chou, Li-Na Lee, et al.Pageof 74